Dr. Ricardo Manuel Quezada, MD

Dr. Quezada practices at Texas Health Arlington Memorial Hospital in Arlington, Texas, part of Texas Health Resources.

Dr. Quezada's NPI, 1053502435, was assigned on August 9, 2007. Dr. Quezada holds Indiana license 01073108A.

Dr. Quezada's primary practice is Texas Health Arlington Memorial Hospital, at 800 W Randol Mill Rd, Arlington, TX 76012 in Tarrant County. The practice phone is (817) 548-6200.

Dr. Quezada's primary practice is Texas Health Arlington Memorial Hospital in Arlington, Texas, part of Texas Health Resources. Dr. Quezada is also affiliated with Texas Health Azle. The medical group on file is Lonestar Hospital Medicine Associates, PA. Dmand AI also links Dr. Quezada to 1 more physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quezada practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Quezada's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Quezada's licenses on file in 2 states: Indiana and Oklahoma.

CMS data shows 604 Medicare services from Dr. Quezada across 3 procedure codes in 2024, for 125 Medicare patients. Medicare paid $57,125 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 125 Medicare patients who saw Dr. Quezada in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Quezada's median patient age at 68, with 56% women.

In 2024, Dr. Quezada wrote 107 Medicare Part D claims for 26 patients. 65% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $1,501 in total drug cost. In 2023, CMS named 59 claims across 3 drugs.

Dr. Quezada accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Quezada as offering telehealth.

CMS Open Payments shows 17 general payments to Dr. Quezada from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Fisher Scientific Company L.L.C. paid the most, $545.